Allogeneic Gammadelta T Cells therapy (Beijing GD Initiative Cell Therapy Technology)

N/A

Report date: 2024/12/20 16:05:25

Base Information

Drug NameAllogeneic Gammadelta T Cells therapy (Beijing GD Initiative Cell Therapy Technology)
Drug Alias NameN/A
ClassificationCell and gene therapy > Cell therapy > Immune system cell therapy > Lymphocytes therapy > T-lymphocyte cell therapy
Mechanisms of ActionT lymphocyte replacements
TargetsNot applicable
Therapy Area/IndicationsCarcinoma, HepatocellularMelanoma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesBeijing GD Initiative Cell Therapy Technology Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesBeijing GD Initiative Cell Therapy Technology Co Ltd
Inactive CompaniesN/A
Active IndicationsCarcinoma, HepatocellularMelanoma
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A